{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T19:27:51Z","timestamp":1789846071252,"version":"4.0.1"},"reference-count":54,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["Fellowships 300639\/2003-1, 310977\/2014-2, 310797\/2015-2 and 404400\/2012-4"],"award-info":[{"award-number":["Fellowships 300639\/2003-1, 310977\/2014-2, 310797\/2015-2 and 404400\/2012-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E-26-201.583\/2014, E-26-102957\/2011 and E-26\/111.682\/2013 and fellowships E-26\/102415\/2010 and E-26\/201747\/2015"],"award-info":[{"award-number":["E-26-201.583\/2014, E-26-102957\/2011 and E-26\/111.682\/2013 and fellowships E-26\/102415\/2010 and E-26\/201747\/2015"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["23038.005304\/2011-0"],"award-info":[{"award-number":["23038.005304\/2011-0"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005671","name":"Funda\u00e7\u00e3o de Apoio \u00e0 Pesquisa e a Inova\u00e7\u00e3o Tecnol\u00f3gica do Estado de Sergipe","doi-asserted-by":"publisher","award":["CNPQ-Funda\u00e7\u00e3o de Apoio \u00e0 Pesquisa e a Inova\u00e7\u00e3o Tecnol\u00f3gica do Estado de Sergipe-PRONEX [12\/2009], FAPITEC CNPq-(PRONEX) [019.203.02712\/2009-8], and research contract funded via VII PN I+D+I 2013\u20132016 and FEDER Funds [RICET RD12\/0018\/0003]"],"award-info":[{"award-number":["CNPQ-Funda\u00e7\u00e3o de Apoio \u00e0 Pesquisa e a Inova\u00e7\u00e3o Tecnol\u00f3gica do Estado de Sergipe-PRONEX [12\/2009], FAPITEC CNPq-(PRONEX) [019.203.02712\/2009-8], and research contract funded via VII PN I+D+I 2013\u20132016 and FEDER Funds [RICET RD12\/0018\/0003]"]}],"id":[{"id":"10.13039\/501100005671","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.00750","type":"journal-article","created":{"date-parts":[[2017,7,12]],"date-time":"2017-07-12T03:51:42Z","timestamp":1499831502000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["F1 Domain of the Leishmania (Leishmania) donovani Nucleoside Hydrolase Promotes a Th1 Response in Leishmania (Leishmania) infantum Cured Patients and in Asymptomatic Individuals Living in an Endemic Area of Leishmaniasis"],"prefix":"10.3389","volume":"8","author":[{"given":"Eugenia","family":"Carrillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Victoria","family":"Ibarra-Meneses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micheli L. B.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirlei","family":"Nico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula M.","family":"de Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane Bani","family":"Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roque Pacheco","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarisa B.","family":"Palatnik-de-Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,7,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"20546","DOI":"10.2807\/1560-7917.ES2013.18.30.20546","article-title":"Re-emergence of leishmaniasis in Spain: community outbreak in Madrid, Spain, 2009 to 2012","volume":"18","author":"Arce","year":"2013","journal-title":"Euro Surveill"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cmi.2016.05.021","article-title":"Interleukin-2 as a marker for detecting asymptomatic individuals in areas where Leishmania infantum is endemic","volume":"22","author":"Ibarra-Meneses","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"B3","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?","volume":"5","author":"Chappuis","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1038\/cti.2014.4","article-title":"Vaccines to prevent leishmaniasis","volume":"3","author":"Kumar","year":"2014","journal-title":"Clin Transl Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4269\/ajtmh.1996.55.125","article-title":"The logic of visceral leishmaniasis control","volume":"55","author":"Dye","year":"1996","journal-title":"Am J Trop Med Hyg"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e3213","DOI":"10.1371\/journal.pntd.0003213","article-title":"A randomised, double-blind, controlled efficacy trial of the LiESP\/QA-21 vaccine in na\u00efve dogs exposed to two Leishmania infantum transmission seasons","volume":"8","author":"Oliva","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"5964","DOI":"10.1016\/j.vaccine.2009.07.069","article-title":"The chimerical multi-component Q protein from Leishmania in the absence of adjuvant protects dogs against an experimental Leishmania infantum infection","volume":"27","author":"Carcel\u00e9n","year":"2009","journal-title":"Vaccine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1586\/14760584.7.6.833","article-title":"The FML-vaccine against canine visceral leishmaniasis: from the second generation to the synthetic vaccine","volume":"7","author":"Palatnik-de-Sousa","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1016\/j.vaccine.2005.11.061","article-title":"The FML-vaccine (Leishmune\u00ae) against canine visceral leishmaniasis: a transmission blocking vaccine","volume":"24","author":"Saraiva","year":"2006","journal-title":"Vaccine"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1016\/j.vaccine.2006.11.057","article-title":"Safety trial using the Leishmune vaccine against canine visceral leishmaniasis in Brazil","volume":"25","author":"Parra","year":"2007","journal-title":"Vaccine"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1016\/j.vaccine.2009.03.045","article-title":"Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune in Brazilian endemic areas","volume":"27","author":"Palatnik-de-Sousa","year":"2009","journal-title":"Vaccine"},{"key":"B12","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.mib.2012.05.002","article-title":"Making an anti-amastigote vaccine for visceral leishmaniasis: rational, update and perspectives","volume":"15","author":"Fernandes","year":"2012","journal-title":"Curr Opin Microbiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"569193","DOI":"10.1155\/2014\/569193","article-title":"Vaccines for canine leishmaniasis","volume":"2014","author":"Foroughi-Parvar","year":"2014","journal-title":"Adv Prev Med"},{"key":"B14","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1128\/IAI.61.3.1069-1073.1993","article-title":"Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis","volume":"61","author":"Kemp","year":"1993","journal-title":"Infect Immun"},{"key":"B15","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/0952-7915(93)90033-O","article-title":"T-cell and cytokine responses in leishmaniasis","volume":"5","author":"Reed","year":"1993","journal-title":"Curr Opin Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3389\/fmicb.2016.00467","article-title":"Post-genomics and vaccine improvement for Leishmania","volume":"7","author":"Seyed","year":"2016","journal-title":"Front Microbiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1111\/j.1469-0691.2011.03610.x","article-title":"Visceral leishmaniasis: immunology and prospects for a vaccine","volume":"17","author":"Kaye","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.1016\/j.vaccine.2012.03.068","article-title":"Leishmaniasis: vaccine candidates and perspectives","volume":"30","author":"Singh","year":"2012","journal-title":"Vaccine"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1016\/S0264-410X(01)00031-7","article-title":"Vaccination of Balb\/c mice against experimental visceral leishmaniasis with the GP36 glycoprotein antigen of Leishmania donovani","volume":"19","author":"Paraguai de Souza","year":"2001","journal-title":"Vaccine"},{"key":"B20","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.4269\/ajtmh.2007.77.1060","article-title":"Protection of susceptible BALB\/c mice from challenge with Leishmania major by nucleoside hydrolase, a soluble exo-antigen of Leishmania","volume":"77","author":"Al-Wabel","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"B21","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1128\/IAI.73.2.812-819.2005","article-title":"Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis","volume":"73","author":"Aguilar-Be","year":"2005","journal-title":"Infect Immun"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e866","DOI":"10.1371\/journal.pntd.0000866","article-title":"Adaptive immunity against Leishmania nucleoside hydrolase maps its c-terminal domain as the target of the CD4+ T cell-driven protective response","volume":"4","author":"Nico","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3389\/fimmu.2014.00273","article-title":"Leishmania donovani nucleoside hydrolase terminal domains in cross-protective immunotherapy against Leishmania amazonensis murine infection","volume":"5","author":"Nico","year":"2014","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3389\/fimmu.2014.00189","article-title":"Cross-protective immunity to Leishmania amazonensis is mediated by CD4+ and CD8+ epitopes of Leishmania donovani nucleoside hydrolase terminal domains","volume":"5","author":"Nico","year":"2014","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3389\/fimmu.2017.00100","article-title":"A chimera containing CD4+ and CD8+ T-cell epitopes of the Leishmania donovani nucleoside hydrolase (NH36) optimizes cross-protection against Leishmania amazonesis infection","volume":"8","author":"Alves-Silva","year":"2017","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.provac.2012.04.009","article-title":"The Leishmune\u2019s nucleoside hydrolase DNA vaccine as an aid in immunotherapy of canine visceral leishmaniasis","volume":"6","author":"Borja-Cabrera","year":"2012","journal-title":"Procedia Vaccinol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.provac.2009.07.019","article-title":"Nucleoside hydrolase DNA vaccine against canine visceral leishmaniasis","volume":"1","author":"Borja-Cabrera","year":"2009","journal-title":"Procedia Vaccinol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3389\/fimmu.2017.00227","article-title":"Leishmania donovani nucleoside hydrolase (NH36) domains induce T-cell cytokine responses in human visceral leishmaniasis","volume":"8","author":"Santos","year":"2017","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"955","DOI":"10.4269\/ajtmh.2012.11-0436","article-title":"Low prevalence of Leishmania infection in post-epidemic areas of Libo Kemkem, Ethiopia","volume":"86","author":"Sordo","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"B30","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ijpara.2004.11.003","article-title":"Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen","volume":"35","author":"Rodrigues","year":"2005","journal-title":"Int J Parasitol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1006\/prep.2002.1628","article-title":"Cloning, overexpression, purification and matrix-assisted refolding of DevS (Rv 3132c) histidine protein kinase of Mycobacterium tuberculosis","volume":"25","author":"Saini","year":"2002","journal-title":"Protein Expr Purif"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e0004179","DOI":"10.1371\/journal.pntd.0004179","article-title":"Cytokine release assays as tests for exposure to Leishmania, and for confirming cure from leishmaniasis, in solid organ transplant recipients","volume":"9","author":"Carrillo","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1756-3305-7-111","article-title":"Serological diagnosis of canine leishmaniosis: comparison of three commercial ELISA tests (Leiscan, ID screen and Leishmania 96), a rapid test (Speed Leish K) and an in-house IFAT","volume":"7","author":"Solano Gallego","year":"2014","journal-title":"Parasit Vectors"},{"key":"B34","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.exppara.2016.09.010","article-title":"Recombinant Leishmania Rab6 (rLdRab6) is recognized by sera from visceral leishmaniasis patients","volume":"170","author":"Chauhuan","year":"2016","journal-title":"Exp Parasitol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/0035-9203(95)90022-5","article-title":"Leishmania donovani: titration of antibodies to the fucose-mannose ligand as an aid in diagnosis and prognosis of visceral leishmaniasis","volume":"89","author":"Palatnik-de-Sousa","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"B36","doi-asserted-by":"publisher","first-page":"296","DOI":"10.4269\/ajtmh.1999.61.296","article-title":"The fucose-mannose ligand-ELISA in the diagnosis and prognosis of canine visceral leishmaniasis in Brazil","volume":"61","author":"Cabrera","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"B37","first-page":"627","article-title":"Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation","volume":"4","author":"Hajian-Tilaki","year":"2013","journal-title":"Caspian J Intern Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8","author":"Seder","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1017\/S0031182099004710","article-title":"Genomic diversity in the Leishmania donovani complex","volume":"119","author":"Mauricio","year":"1999","journal-title":"Parasitology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/S0169-4758(00)01637-9","article-title":"The strange case of Leishmania chagasi","volume":"16","author":"Maur\u00edcio","year":"2000","journal-title":"Parasitol Today"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1086\/513439","article-title":"HLA class I-restricted T cell epitopes of the kinetoplastid membrane protein-11 presented by Leishmania donovani-infected human macrophages","volume":"195","author":"Basu","year":"2007","journal-title":"J Infect Dis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"7036","DOI":"10.1016\/j.vaccine.2009.09.066","article-title":"Optimized subunit vaccine protects against experimental leishmaniasis","volume":"27","author":"Bertholet","year":"2009","journal-title":"Vaccine"},{"key":"B43","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.pt.2013.10.007","article-title":"What is responsible for a large and unusual outbreak of leishmaniasis in Madrid?","volume":"29","author":"Carrillo","year":"2013","journal-title":"Trends Parasitol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1172\/JCI38813","article-title":"IL-17 and IL-22 are associated with protection against human Kala-azar caused by Leishmania donovani","volume":"119","author":"Pitta","year":"2009","journal-title":"J Clin Invest"},{"key":"B45","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1365-3024.2010.01256.x","article-title":"IL-17 and regulatory cytokines (IL-10 and IL-27) in L. braziliensis infection","volume":"33","author":"Novoa","year":"2011","journal-title":"Parasite Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/infdis\/jiu531","article-title":"Interleukin 17A acts synergistically with interferon gamma to promote protection against Leishmania infantum infection","volume":"211","author":"Nascimento","year":"2015","journal-title":"J Infect Dis"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e0147076","DOI":"10.1371\/journal.pone.0147076","article-title":"Prediction of T cell epitopes from Leishmania major potentially excreted\/secreted proteins inducing granzyme B production","volume":"11","author":"Naouar","year":"2016","journal-title":"PLoS One"},{"key":"B48","volume-title":"Induction of Immune Response against Desired Determinants","author":"Alexander","year":"1997"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e92708","DOI":"10.1371\/journal.pone.0092708","article-title":"In vitro evaluation of a soluble Leishmania promastigote surface antigen as a potential vaccine candidate against human leishmaniasis","volume":"9","author":"Chamakh-Ayari","year":"2014","journal-title":"PLoS One"},{"key":"B50","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1128\/CDLI.6.2.231-235.1999","article-title":"Immunoglobulin subclass distribution and diagnostic value of Leishmania donovani antigen-specific immunoglobulin G3 in indian Kala-azar patients","volume":"6","author":"Anam","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e1622","DOI":"10.1371\/journal.pntd.0001622","article-title":"Improved canine and human visceral leishmaniasis immunodiagnosis using combinations of synthetic peptides in enzyme-linked immunosorbent assay","volume":"6","author":"Costa","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e0134835","DOI":"10.1371\/journal.pone.0134835","article-title":"Analysis of conformational B-cell epitopes in the antibody-antigen complex using the depth function and the convex hull","volume":"10","author":"Zheng","year":"2015","journal-title":"PLoS One"},{"key":"B53","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1590\/S0037-86821996000200008","article-title":"The FML (fucose mannose ligand) of Leishmania donovani. A new tool in diagnosis, prognosis, transfusional control and vaccination against human Kala-azar","volume":"29","author":"Palatnik de Sousa","year":"1996","journal-title":"Rev Soc Bras Med Trop"},{"key":"B54","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0166-6851(02)00010-5","article-title":"Nucleoside hydrolase from Leishmania donovani is an antigen diagnostic for visceral leishmaniasis","volume":"120","author":"Santana","year":"2002","journal-title":"Mol Biochem Parasitol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00750\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T02:20:39Z","timestamp":1602469239000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00750\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,12]]},"references-count":54,"alternative-id":["10.3389\/fimmu.2017.00750"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.00750","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,12]]},"article-number":"750"}}